Blog

Product Spotlight: Complex Lipids Targeted Panel

lipids targeted panel

The study of complex lipids is critical to gaining insight across a variety of biological processes. From the structure of biological membranes to signaling lipids, to energy storage, the identification and quantification of complex lipids reveal key understandings of the physiology and mechanisms underlying metabolic diseases.

The Basics of Complex Lipid Structure

Complex lipids are extraordinarily diverse with thousands of unique species. Complex lipids have a modular structure, consisting of lipid classes consisting of a head group, which defines the class, and one or more fatty acid moieties. Together, a matrix is constructed with lipid classes forming the columns and fatty acids forming the rows. Concentration can then be calculated by the sum of each row for fatty acids and the sum of each column for lipid classes.

Challenges and Essentials for Lipidomics

Given the diversity in lipid structure, lipidomics faces several challenges. Due to a large number of isomers, exact mass is not sufficient to identify lipids. Moreover, many isomers are not readily separated by chromatography and many standards are not commercially available. The matrix structure of complex lipids presents three essentials for accurate lipidomic profiling that come with their own challenges:

  • Specificity—The lipidomic profiling method must accurately identify the fatty acid constituent of the lipid. Many methods fail to resolve fatty acid composition, and non-specific methods do not allow mapping of lipid species to the matrix.
  • Quantitation—The lipidomic profiling method must provide accurate summing of rows and columns. In other words, the molar concentration of each lipid species is required. Quantitation using relative methods does not provide accurate measures for lipid class or fatty acids.
  • Coverage—The lipidomic profiling method must provide broad coverage. A partially completed matrix will not provide an accurate representation of the contribution of a lipid class or fatty acid.

Metabolon’s Complex Lipids Targeted Panel

Metabolon’s solution for these challenges is the Complex Lipids Targeted Panel. Developed in partnership with scientists from SCIEX, the panel consists of several analytical steps designed for confident and accurate identification and quantitation of hundreds of lipids.

The Complex Lipids Targeted Panel begins by adding proprietary internal standard mixure designed to allow for differing extraction and ionization efficiencies to the sample before lipid extraction. The panel is capable of delivering quantitative values. Next, the lipid-containing solution is infused into the ionization source of a QTRAP 5500 mass spectrometer. After ionization, the lipids are passed through SelexION differential mobility separation (DMS). Since SelexION separates lipids by class through the selective passage of specific lipid classes, this minimizes isobaric overlaps. Following DMS, lipids enter multiple reaction monitoring (MRM) where the impact mass of the lipid and the mass of the characteristic fragments are measured, allowing for the identification of fatty acid side chains. Finally, quantitation occurs using more than 50 isotopically labeled internal standards, permitting accurate quantitation across and within lipid classes. Intensity data are collected and calculated to obtain a molar concentration of each lipid.

The Complex Lipids Targeted Panel not only meets key lipidomic challenges, but is also high throughput, providing broad coverage of over 1,100 typical mammalian lipids. At least 800 of these species are detected in human plasma, achieved without sacrificing speed (total runtime: 16 min/sample).

Ready to see what new insights the Complex Lipids Targeted Panel can help your research reveal? 

Contact us today to learn more.

Metabolon
Our team is made up of over 45 PhDs, has been published 4,000+ times, and is committed to hard work, excellence, and success through collaboration. With over 15,000 projects, Metabolon has been a trusted partner of researchers for over 25 years.

Topics

Share this article

GET STARTED

Talk with an expert

Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.

Find us on:

Talk with a Metabolomics expert

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.